KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Inventory Average (2020 - 2025)

Esperion Therapeutics' Inventory Average history spans 6 years, with the latest figure at $106.8 million for Q4 2025.

  • For Q4 2025, Inventory Average rose 22.38% year-over-year to $106.8 million; the TTM value through Dec 2025 reached $106.8 million, up 22.38%, while the annual FY2025 figure was $99.8 million, 24.67% up from the prior year.
  • Inventory Average reached $106.8 million in Q4 2025 per ESPR's latest filing, down from $111.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $111.5 million in Q3 2025 to a low of $18.1 million in Q1 2021.
  • Average Inventory Average over 5 years is $57.9 million, with a median of $45.5 million recorded in 2023.
  • Peak YoY movement for Inventory Average: surged 333.58% in 2021, then decreased 5.3% in 2022.
  • A 5-year view of Inventory Average shows it stood at $34.2 million in 2021, then fell by 5.3% to $32.4 million in 2022, then soared by 80.8% to $58.5 million in 2023, then skyrocketed by 49.15% to $87.3 million in 2024, then grew by 22.38% to $106.8 million in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Inventory Average are $106.8 million (Q4 2025), $111.5 million (Q3 2025), and $106.9 million (Q2 2025).